BeyondSpring Inc. — Investor Relations & Filings
Filings indexed
233
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
BYSI
BeyondSpring Inc. is a clinical-stage biopharmaceutical company that develops innovative immuno-oncology cancer therapies. The company's primary focus is on addressing unmet medical needs and improving clinical outcomes for cancer patients. Its pipeline includes a lead asset, Plinabulin, which is a first-in-class small molecule agent. Additionally, the company operates a Targeted Protein Degradation (TPD) platform to advance other potential treatments. BeyondSpring is committed to developing novel cancer therapies to enhance the standard of care in oncology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-05-13 | English | |
| 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-03-25 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| FORM 8-K | 2025-12-15 | English | |
| FORM 8-K | 2025-11-21 | English | |
| 424B5 | 2025-11-17 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 45554257 | 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-05-13 | English | ||
| 33040006 | 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-03-25 | English | ||
| 31261765 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
12 filings
| |||||
| 12967326 | FORM 8-K | 2025-12-15 | English | ||
| 12967325 | FORM 8-K | 2025-11-21 | English | ||
| 12967327 | 424B5 | 2025-11-17 | English | ||
| 12967328 | FORM 10-Q | 2025-11-12 | English | ||
| 12967329 | FORM 8-K | 2025-11-12 | English | ||
| 12967330 | Director's Dealing 2025 | 2025-10-20 | English | ||
| 12967331 | Director's Dealing 2025 | 2025-10-15 | English | ||
| 12967333 | Director's Dealing 2025 | 2025-10-10 | English | ||
| 12967332 | Director's Dealing 2025 | 2025-10-07 | English | ||
| 12967334 | Director's Dealing 2025 | 2025-10-02 | English | ||
| 12967335 | Director's Dealing 2025 | 2025-09-29 | English | ||
| 12967336 | Director's Dealing 2025 | 2025-09-24 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
|
CG Oncology, Inc.
Develops bladder-sparing oncolytic immunotherapies for urol…
|
CGON | US | Manufacturing |
BeyondSpring Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34404/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34404 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34404 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34404 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34404}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BeyondSpring Inc. (id: 34404)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.